IL-6 pathway in the liver: From physiopathology to therapy

Acute-Phase Proteins and Other Systemic Responses to Inflammation

Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734 · see citing works

C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus

Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433 · see citing works

Obesity and the Metabolic Syndrome in Children and Adolescents

Weiss, R., Dziura, J., Burgert, T. S., Tamborlane, W. V., Taksali, S. E., Yeckel, C. W., Allen, K., Lopes, M., Savoye, M., Morrison, J. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031049 · Cited by 3,458 · see citing works

Muscles, exercise and obesity: skeletal muscle as a secretory organ

Pedersen, B. K., & Febbraio, M. A. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.49 · Cited by 2,909 · see citing works

The acute phase response

Baumann, H., & Gauldie, J. (1994) · Immunology Today · doi:10.1016/0167-5699(94)90137-6 · Cited by 2,907 · see citing works

Liver Regeneration

Michalopoulos, G. K., & DeFrances, M. C. (1997) · Science · doi:10.1126/science.276.5309.60 · Cited by 2,828 · see citing works

IL-6 as a keystone cytokine in health and disease

Hunter, C. A., & Jones, S. A. (2015) · Nature Immunology · doi:10.1038/ni.3153 · Cited by 2,511 · see citing works

NF-κB functions as a tumour promoter in inflammation-associated cancer

Pikarsky, E., Porat, R., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,295 · see citing works

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

Hirano, T., Yasukawa, K., Harada, H., Taga, T., Watanabe, Y., Matsuda, T., Kashiwamura, S.-I., Nakajima, K., Koyama, K., Iwamatsu, A., et al. (1986) · Nature · doi:10.1038/324073a0 · Cited by 2,139 · see citing works

Gender Disparity in Liver Cancer Due to Sex Differences in MyD88-Dependent IL-6 Production

Naugler, W. E., Sakurai, T., Kim, S., Maeda, S., Kim, K., Elsharkawy, A. M., & Karin, M. (2007) · Science · doi:10.1126/science.1140485 · Cited by 1,955 · see citing works

Impaired immune and acute-phase responses in interleukin-6-deficient mice

Kopf, M., Baumann, H., Freer, G., Freudenberg, M., Lamers, M., Kishimoto, T., Zinkernagel, R., Bluethmann, H., & Köhler, G. (1994) · Nature · doi:10.1038/368339a0 · Cited by 1,768 · see citing works

Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression

Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764 · see citing works

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Gauldie, J., Richards, C. D., Harnish, D. C., Lansdorp, P. M., & Baumann, H. J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.20.7251 · Cited by 1,635 · see citing works

Liver regeneration: from myth to mechanism

Taub, R. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1489 · Cited by 1,567 · see citing works

Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice

Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., & Taub, R. (1996) · Science · doi:10.1126/science.274.5291.1379 · Cited by 1,536 · see citing works

Interleukin-6-deficient mice develop mature-onset obesity

Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · see citing works

Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.

Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,181 · see citing works

IKKβ Couples Hepatocyte Death to Cytokine-Driven Compensatory Proliferation that Promotes Chemical Hepatocarcinogenesis

Maeda, S., Kamata, H., Luo, J., Leffert, H. L., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2005.04.014 · Cited by 1,165 · see citing works

Interleukin-6: from basic science to medicine--40 years in immunology.

Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,083 · see citing works

IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6

Rose-John, S. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4989 · Cited by 1,040 · see citing works

IL-6: From its discovery to clinical applications

Kishimoto, T. (2010) · International Immunology · doi:10.1093/intimm/dxq030 · Cited by 846 · see citing works

Soluble receptors for cytokines and growth factors: generation and biological function

Rose‐John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 784 · see citing works

Humanized anti–interleukin-6 receptor antibody treatment of multicentric Castleman disease

Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4602 · Cited by 754 · see citing works

A Switch from White to Brown Fat Increases Energy Expenditure in Cancer-Associated Cachexia

Petruzzelli, M., Schweiger, M., Schreiber, R., Campos‐Olivas, R., Tsoli, M., Allen, J., Swarbrick, M. M., Rose‐John, S., Rincón, M., Robertson, G. R., et al. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.06.011 · Cited by 752 · see citing works

Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma

Li, X., Yao, W., Yuan, Y., Chen, P., Li, B., Li, J., Chu, R., Song, H., Xie, D., Jiang, X., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-310514 · Cited by 739 · see citing works

Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin

Mauer, J., Chaurasia, B., Goldau, J., Vogt, M. C., Ruud, J., Nguyen, K. D., Theurich, S., Hausen, A. C., Schmitz, J., Brönneke, H. S., et al. (2014) · Nature Immunology · doi:10.1038/ni.2865 · Cited by 727 · see citing works

Liver Regeneration after Partial Hepatectomy

Michalopoulos, G. K. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090675 · Cited by 713 · see citing works

Insulin Action in AgRP-Expressing Neurons Is Required for Suppression of Hepatic Glucose Production

Könner, A. C., Janoschek, R., Plum, L., Jordan, S. D., Rother, E., Ma, X., Xu, C., Enriori, P., Hampel, B., Barsh, G. S., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.004 · Cited by 695 · see citing works

Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms

Ueki, K., Kondo, T., & Kahn, C. R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5434-5446.2004 · Cited by 686 · see citing works

Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells

Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D. M., Zou, W., & Welling, T. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.08.039 · Cited by 676 · see citing works

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial

Gabay, C., Emery, P., van Vollenhoven, R., Dikranian, A., Alten, R., Pavelka, K., Klearman, M., Musselman, D., Agarwal, S., Green, J., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60250-0 · Cited by 672 · see citing works

Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.

Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M., & Rose-John, S. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.01867.x · Cited by 665 · see citing works

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

Iliopoulos, D., Hirsch, H. A., Wang, G., & Struhl, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018898108 · Cited by 642 · see citing works

Interleukin 6: from bench to bedside

Nishimoto, N., & Kishimoto, T. (2006) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0338 · Cited by 639 · see citing works

A gp130–Src–YAP module links inflammation to epithelial regeneration

Taniguchi, K., Wu, L.-W., Grivennikov, S. I., de Jong, P. R., Lian, I., Yu, F.-X., Wang, K., Ho, S. B., Boland, B. S., Chang, J. T., et al. (2015) · Nature · doi:10.1038/nature14228 · Cited by 633 · see citing works

A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance

Sabio, G., Das, M., Mora, A., Zhang, Z., Jun, J. Y., Ko, H. J., Barrett, T., Kim, J. K., & Davis, R. J. (2008) · Science · doi:10.1126/science.1160794 · Cited by 604 · see citing works

Differential Effects of Interleukin-6 and -10 on Skeletal Muscle and Liver Insulin Action In Vivo

Kim, H.-J., Higashimori, T., Park, S.-Y., Choi, H., Dong, J., Kim, Y.-J., Noh, H.-L., Cho, Y.-R., Cline, G., Kim, Y.-B., et al. (2004) · Diabetes · doi:10.2337/diabetes.53.4.1060 · Cited by 534 · see citing works

Bipotential Adult Liver Progenitors Are Derived from Chronically Injured Mature Hepatocytes

Tarlow, B. D., Pelz, C., Naugler, W. E., Wakefield, L., Wilson, E. M., Finegold, M. J., & Grompe, M. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.09.008 · Cited by 533 · see citing works

A bioactive designer cytokine for human hematopoietic progenitor cell expansion

Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P. J., Kallen, K., Wollmer, A., Grötzinger, J., & Rose‐John, S. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-142 · Cited by 532 · see citing works

Interleukin-6: Biology, signaling and strategies of blockade

Schaper, F., & Rose‐John, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.004 · Cited by 511 · see citing works

The soluble interleukin‐6 receptor is generated by shedding

Müllberg, J., Schooltink, H., Stoyan, T., Günther, M., Graeve, L., Buse, G., Mackiewicz, A. A., Heinrich, P. C., & Rose‐John, S. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230226 · Cited by 507 · see citing works

Hepatic progenitor cells of biliary origin with liver repopulation capacity

Lu, W.-Y., Bird, T. G., Boulter, L., Tsuchiya, A., Cole, A. M., Hay, T., Guest, R. V., Wojtacha, D., Man, T. Y., Mackinnon, A., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3203 · Cited by 479 · see citing works

Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours

Rebouissou, S., Amessou, M., Couchy, G., Poussin, K., Imbeaud, S., Pilati, C., Izard, T., Balabaud, C., Bioulac-Sage, P., & Zucman-Rossi, J. (2009) · Nature · doi:10.1038/nature07475 · Cited by 477 · see citing works

Identification of Liver Cancer Progenitors Whose Malignant Progression Depends on Autocrine IL-6 Signaling

He, G., Dhar, D., Nakagawa, H., Font-Burgada, J., Ogata, H., Jiang, Y., Shalapour, S., Seki, E., Yost, S. E., Jepsen, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.031 · Cited by 469 · see citing works

SERUM C‐REACTIVE PROTEIN LEVELS IN DISEASE *

Morley, J. J., & Kushner, I. (1982) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1982.tb22153.x · Cited by 467 · see citing works

Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma

Finkin, S., Yuan, D., Stein, I., Taniguchi, K., Weber, A., Unger, K., Browning, J. L., Goossens, N., Nakagawa, S., Gunasekaran, G., et al. (2015) · Nature Immunology · doi:10.1038/ni.3290 · Cited by 433 · see citing works

The IL-6/gp130/STAT3 signaling axis: recent advances towards specific inhibition

Garbers, C., Aparicio-Siegmund, S., & Rose‐John, S. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.02.008 · Cited by 432 · see citing works

Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia

Klein, B., Wijdenes, J., Zhang, X., Jourdan, M., Boiron, J.-M., Brochier, J., Liautard, J., Merlin, M., Clement, C., & Morel-Fournier, B. (1991) · Blood · doi:10.1182/blood.v78.5.1198.1198 · Cited by 418 · see citing works

Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo

Inoue, H., Ogawa, W., Ozaki, M., Haga, S., Matsumoto, M., Furukawa, K., Hashimoto, N., Kido, Y., Mori, T., Sakaue, H., et al. (2004) · Nature Medicine · doi:10.1038/nm980 · Cited by 384 · see citing works

Hepatic acute phase proteins – Regulation by IL-6- and IL-1-type cytokines involving STAT3 and its crosstalk with NF-κB-dependent signaling

Bode, J. G., Albrecht, U., Häussinger, D., Heinrich, P. C., & Schaper, F. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.09.008 · Cited by 379 · see citing works

Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins

Mackiewicz, A. A., Schooltink, H., Heinrich, P. C., & Rose‐John, S. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.6.2021 · Cited by 369 · see citing works

Interleukin-6 released by colon cancer-associated fibroblasts is critical for tumour angiogenesis: anti-interleukin-6 receptor antibody suppressed angiogenesis and inhibited tumour–stroma interaction

Nagasaki, T., Hara, M., Nakanishi, H., Takahashi, H., Sato, M., & Takeyama, H. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.748 · Cited by 363 · see citing works

Not interferon, but interleukin‐6 controls early gene expression in hepatitis B virus infection

Hösel, M., Quasdorff, M., Wiegmann, K., Webb, D., Zedler, U., Broxtermann, M., Tedjokusumo, R., Esser, K., Arzberger, S., Kirschning, C. J., et al. (2009) · Hepatology · doi:10.1002/hep.23226 · Cited by 360 · see citing works

Sympathetic neurons can produce and respond to interleukin 6.

März, P., Cheng, J. G., Gadient, R., Patterson, P. H., Stoyan, T., Otten, U., & Rose-John, S. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.6.3251 · Cited by 346 · see citing works

Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance

Matthews, V. B., Allen, T. L., Risis, S., Chan, M. H. S., Henstridge, D. C., Watson, N., Zaffino, L. A., Babb, J. R., Boon, J., Meikle, P. J., et al. (2010) · Diabetologia · doi:10.1007/s00125-010-1865-y · Cited by 334 · see citing works

IL-6 biology: implications for clinical targeting in rheumatic disease

Calabrese, L., & Rose-John, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.127 · Cited by 329 · see citing works

Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease

Aravinthan, A., Scarpini, C., Tachtatzis, P., Verma, S., Penrhyn-Lowe, S., Harvey, R., Davies, S. E., Allison, M., Coleman, N., & Alexander, G. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.031 · Cited by 326 · see citing works

PGRN is a Key Adipokine Mediating High Fat Diet-Induced Insulin Resistance and Obesity through IL-6 in Adipose Tissue

Matsubara, T., Mita, A., Minami, K., Hosooka, T., Kitazawa, S., Takahashi, K., Tamori, Y., Yokoi, N., Watanabe, M., Matsuo, E., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.12.002 · Cited by 286 · see citing works

Molecular Pathways: JAK/STAT Pathway: Mutations, Inhibitors, and Resistance

Quintás‐Cardama, A., & Verstovšek, S. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0284 · Cited by 284 · see citing works

Adiponectin Enhances Insulin Sensitivity by Increasing Hepatic IRS-2 Expression via a Macrophage-Derived IL-6-Dependent Pathway

Awazawa, M., Ueki, K., Inabe, K., Yamauchi, T., Kubota, N., Kaneko, K., Kobayashi, M., Iwane, A., Sasako, T., Okazaki, Y., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.010 · Cited by 277 · see citing works

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6.

Peters, M. J., Jacobs, S., Ehlers, M., Vollmer, P., Müllberg, J., Wolf, E., Brem, G., Büschenfelde, K. H. M. Z., & Rose‐John, S. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1399 · Cited by 276 · see citing works

Blocking IL-6 trans-signaling prevents high-fat diet-induced adipose tissue macrophage recruitment but does not improve insulin resistance

Kraakman, M. J., Kammoun, H. L., Allen, T. L., Deswaerte, V., Henstridge, D. C., Estevez, E., Matthews, V. B., Neill, B., White, D. A., Murphy, A. J., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.006 · Cited by 257 · see citing works

The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex

Jones, S. A., & Rose‐John, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00319-1 · Cited by 256 · see citing works

Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain

Campbell, I. L., Erta, M., Lim, S. L., Frausto, R. F., May, U., Rose‐John, S., Scheller, J., & Hidalgo, J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2830-13.2014 · Cited by 247 · see citing works

Transgenic blockade of interleukin 6 transsignaling abrogates inflammation

Rabe, B., Chalaris, A., May, U., Waetzig, G. H., Seegert, D., Williams, A. S., Jones, S. A., Rose‐John, S., & Scheller, J. (2007) · Blood · doi:10.1182/blood-2007-07-102137 · Cited by 244 · see citing works

EGFR has a tumour-promoting role in liver macrophages during hepatocellular carcinoma formation

Lanaya, H., Natarajan, A., Komposch, K., Li, L., Amberg, N., Chen, L., Wculek, S. K., Hammer, M., Zenz, R., Peck‐Radosavljevic, M., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3031 · Cited by 243 · see citing works

Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas

Pilati, C., Amessou, M., Bihl, M., Balabaud, C. P., Nhieu, J. T. V., Paradis, V., Nault, J., Izard, T., Bioulac‐Sage, P., Couchy, G., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110283 · Cited by 242 · see citing works

Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis

Tabibian, J. H., O'Hara, S. P., Splinter, P. L., Trussoni, C. E., & LaRusso, N. F. (2014) · Hepatology · doi:10.1002/hep.26993 · Cited by 241 · see citing works

Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action

Wunderlich, F. T., Ströhle, P., Könner, A. C., Gruber, S., Tovar, S., Brönneke, H. S., Juntti-Berggren, L., Li, L.-S., van Rooijen, N., Libert, C., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.06.011 · Cited by 229 · see citing works

Localization of estrogen receptor ?-immunoreactivity in astrocytes of the adult rat brain

Azcoitia, Í., Sierra, A., & García‐Segura, L. M. (1999) · Glia · doi:10.1002/(sici)1098-1136(199905)26:3 · Cited by 222 · see citing works

Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial

Kennedy, G., Varelias, A., Vučković, S., Texier, L. L., Gartlan, K. H., Zhang, P., Thomas, G. P., Anderson, L. K., Boyle, G. M., Cloonan, N., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71017-4 · Cited by 217 · see citing works

Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment

Mu, X., Español‐Suñer, R., Mederacke, I., Affò, S., Manco, R., Sempoux, C. L., Lemaigre, F. P., Adili, A., Yuan, D., Weber, A., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77995 · Cited by 214 · see citing works

Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer

Aleksandrova, K., Boeing, H., Nöthlings, U., Jenab, M., Fedirko, V., Kaaks, R., Lukanova, A., Trichopoulou, A., Trichopoulos, D., Boffetta, P., et al. (2014) · Hepatology · doi:10.1002/hep.27016 · Cited by 210 · see citing works

STAT3 inhibition, a novel approach to enhancing targeted therapy in human cancers

Wang, X., Crowe, P. J., Goldstein, D., & Yang, J. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1568 · Cited by 202 · see citing works

A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors

Angevin, E., Tabernero, J., Élez, E., Cohen, S. J., Bahleda, R., Laethem, J. V., Ottensmeier, C., López-Martín, J., Clive, S., Joly, F., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2200 · Cited by 183 · see citing works

High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production.

Deviere, J. M. E., Content, J., Denys, C. H., Vandenbussche, P., Schandené, L., Wybran, J., & Dupont, E. (1989) · PubMed Central · Cited by 181 · see citing works

Novel Path to Activation of Vascular Smooth Muscle Cells: Up-Regulation of gp130 Creates an Autocrine Activation Loop by IL-6 and Its Soluble Receptor

Klouche, M., Bhakdi, S., Hemmes, M., & Rose‐John, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.8.4583 · Cited by 178 · see citing works

Extramedullary Expansion of Hematopoietic Progenitor Cells in Interleukin (IL)-6–sIL-6R Double Transgenic Mice

Peters, M., Schirmacher, P., Goldschmitt, J., Odenthal, M., Peschel, C., Fattori, E., Ciliberto, G., Dienes, H., Buschenfelde, K. Z. Z., & Rose-John, S. (1997) · Journal of Experimental Medicine · doi:10.1084/jem.185.4.755 · Cited by 176 · see citing works

Humanized Anti-Interleukin-6 Receptor Antibody Suppresses Tumor Angiogenesis and In vivo Growth of Human Oral Squamous Cell Carcinoma

Shinriki, S., Jono, H., Ota, K., Ueda, M., Kudo, M., Ota, T., Oike, Y., Endo, M., Ibusuki, M., Hiraki, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0287 · Cited by 163 · see citing works

A Portal Blood Factor as the Humoral Agent in Liver Regeneration

Fisher, B., Szuch, P., Levine, M., & Fisher, E. R. (1971) · Science · doi:10.1126/science.171.3971.575 · Cited by 161 · see citing works

Development of a Novel Azaspirane That Targets the Janus Kinase-Signal Transducer and Activator of Transcription (STAT) Pathway in Hepatocellular Carcinoma in Vitro and in Vivo

Mohan, C. D., Bharathkumar, H., Bulusu, K. C., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.601104 · Cited by 159 · see citing works

IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling

Hoge, J., Yan, I., Jänner, N., Schumacher, V., Chalaris, A., Steinmetz, O. M., Engel, D. R., Scheller, J., Rose‐John, S., & Mittrücker, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201044 · Cited by 151 · see citing works

Deletion of Skeletal Muscle SOCS3 Prevents Insulin Resistance in Obesity

Jørgensen, S. B., O’Neill, H. M., Sylow, L., Honeyman, J. E., Hewitt, K. A., Palanivel, R., Fullerton, M. D., Öberg, L., Balendran, A., Galić, S., et al. (2012) · Diabetes · doi:10.2337/db12-0443 · Cited by 149 · see citing works

Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells

Audet, J., Miller, C., Rose‐John, S., Piret, J. M., & Eaves, C. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1757 · Cited by 137 · see citing works

Acute-phase response factor, increased binding, and target gene transcription during liver regeneration

Trautwein, C., Rakemann, T., Niehof, M., Rose-John, S., & Manns, M. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8964411 · Cited by 131 · see citing works

Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia.

Ando, K., Takahashi, F., Motojima, S., Nakashima, K., Kaneko, N., Hoshi, K., & Takahashi, K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.2020 · Cited by 131 · see citing works

Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration

Peters, M., Blinn, G., Jostock, T., Schirmacher, P., Büschenfelde, K. M. Z., Galle, P. R., & Rose–John, S. (2000) · Gastroenterology · doi:10.1053/gast.2000.20236 · Cited by 129 · see citing works

Coexpression of IL‐6 and soluble IL‐6R causes nodular regenerative hyperplasia and adenomas of the liver

Maione, D., Carlo, E. D., Li, W., Musiani, P., Modesti, A., Peters, M., Rose‐John, S., Rocca, C. D., Tripodi, M., Lazzaro, D., et al. (1998) · The EMBO Journal · doi:10.1093/emboj/17.19.5588 · Cited by 128 · see citing works

Constitutive STAT3 Phosphorylation Contributes to Skeletal Muscle Insulin Resistance in Type 2 Diabetes

Mashili, F. L., Chibalin, A., Krook, A., & Zierath, J. R. (2012) · Diabetes · doi:10.2337/db12-0337 · Cited by 125 · see citing works

Liver regeneration induced by a designer human IL‐6/ sIL‐6R fusion protein reverses severe hepatocellular injury

Galun, E., Zeira, E., Pappo, O., Peters, M., & Rose-John, S. (2000) · The FASEB Journal · doi:10.1096/fj.99-0913com · Cited by 124 · see citing works

Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma

Soresi, M. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i16.2563 · Cited by 115 · see citing works

In Vivo and In Vitro Activities of the gp130-Stimulating Designer Cytokine Hyper-IL-6

Peters, M., Blinn, G., Solem, F. K., Fischer, M., Büschenfelde, K. M. Z., & Rose‐John, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3575 · Cited by 104 · see citing works

STAT3 targets the regulatory regions of gluconeogenic genes in vivo

Ramadoss, P., Unger-Smith, N. E., Lam, F. S., & Hollenberg, A. N. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0264 · Cited by 103 · see citing works

High amounts of circulating interleukin (IL)‐6 in the form of monomeric immune complexes during anti‐IL‐6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo

Lu, Z., Brochier, J., Wijdenes, J., Brailly, H., Bataille, R., & Klein, B. (1992) · European Journal of Immunology · doi:10.1002/eji.1830221110 · Cited by 102 · see citing works

Opposing roles of gp130-mediated STAT-3 and ERK-1/2 signaling in liver progenitor cell migration and proliferation

Yeoh, G. C., Ernst, M., Rose‐John, S., Akhurst, B., Payne, C. J., Long, S., Alexander, W. S., Croker, B. A., Grail, D., & Matthews, V. B. (2007) · Hepatology · doi:10.1002/hep.21535 · Cited by 102 · see citing works

Therapy for myeloproliferative neoplasms: when, which agent, and how?

Geyer, H. L., & Mesa, R. A. (2014) · Blood · doi:10.1182/blood-2014-05-577635 · Cited by 97 · see citing works

Ligand/Receptor Signaling Threshold (LIST) Model Accounts for gp130‐Mediated Embryonic Stem Cell Self‐Renewal Responses to LIF and HIL‐6

Viswanathan, S., Benatar, T., Rose‐John, S., Lauffenburger, D. A., & Zandstra, P. W. (2002) · Stem Cells · doi:10.1634/stemcells.20-2-119 · Cited by 92 · see citing works

Hepatocellular Hyperplasia, Plasmacytoma Formation, and Extramedullary Hematopoiesis in Interleukin (IL)-6/Soluble IL-6 Receptor Double-Transgenic Mice

Schirmacher, P., Peters, M., Ciliberto, G., Blessing, M., Lotz, J., Büschenfelde, K. M. Z., & Rose‐John, S. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65605-2 · Cited by 87 · see citing works

Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration

Drucker, C., Gewiese, J., Malchow, S., Scheller, J., & Rose-John, S. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.08.003 · Cited by 83 · see citing works

Ciliary neurotrophic factor induces acute‐phase protein expression in hepatocytes

Schooltink, H., Stoyan, T., Roeb, E., Heinrich, P. C., & Rose‐John, S. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81489-9 · Cited by 81 · see citing works

Lack of interleukin-6/glycoprotein 130/signal transducers and activators of transcription-3 signaling in hepatocytes predisposes to liver steatosis and injury in mice

Kroy, D. C., Beraza, N., Tschaharganeh, D. F., Sander, L. E., Erschfeld, S., Giebeler, A., Liedtke, C., Wasmuth, H. E., Trautwein, C., & Streetz, K. L. (2010) · Hepatology · doi:10.1002/hep.23322 · Cited by 76 · see citing works

Hyper-IL-6 Gene Therapy Reverses Fulminant Hepatic Failure

Hecht, N., Pappo, O., Shouval, D., Rose‐John, S., Galun, E., & Axelrod, J. H. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0313 · Cited by 74 · see citing works

Signal Transducer and Activator of Transcription 3 Protects From Liver Injury and Fibrosis in a Mouse Model of Sclerosing Cholangitis

Mair, M., Zollner, G., Schneller, D., Musteanu, M., Fickert, P., Gumhold, J., Schuster, C., Fuchsbichler, A., Bilban, M., Tauber, S., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.02.049 · Cited by 74 · see citing works

The interleukin 6 pathway and atherosclerosis

Scheller, J., & Rose‐John, S. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61246-x · Cited by 68 · see citing works

NCOA5 Haploinsufficiency Results in Glucose Intolerance and Subsequent Hepatocellular Carcinoma

Gao, S., Li, A., Liu, F., Chen, F., Williams, M., Zhang, C., Kelley, Z., Wu, C., Luo, R., & Xiao, H. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.11.005 · Cited by 67 · see citing works

Acute Phase Protein α1-Antitrypsin Reduces the Bacterial Burden in Mice by Selective Modulation of Innate Cell Responses

Kaner, Z., Ochayon, D. E., Shahaf, G., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu620 · Cited by 62 · see citing works

Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro

Wilson, G. S., Tian, A., Hebbard, L., Duan, W., George, J., Li, X., & Qiao, L. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.009 · Cited by 61 · see citing works

Role of IL-6 trans-signaling in CCl4 induced liver damage

Gewiese, J., Drucker, C., Malchow, S., Scheller, J., & Rose‐John, S. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.023 · Cited by 47 · see citing works

Biochemical and functional analyses of gp130 mutants unveil JAK1 as a novel therapeutic target in human inflammatory hepatocellular adenoma

Poussin, K., Pilati, C., Couchy, G., Caldéraro, J., Bioulac‐Sage, P., Bacq, Y., Paradis, V., Leteurtre, E., Stürm, N., Ramos, J., et al. (2013) · OncoImmunology · doi:10.4161/onci.27090 · Cited by 44 · see citing works

Essential role of neutrophil mobilization in concanavalin A-induced hepatitis is based on classic IL-6 signaling but not on IL-6 trans-signaling.

Malchow, S., Thaiss, W. M., Jänner, N., Waetzig, G. H., Gewiese-Rabsch, J., Garbers, C., Yamamoto, K., Rose-John, S., & Scheller, J. (2011) · Biochimica et Biophysica Acta · doi:10.1016/j.bbadis.2010.11.009 · Cited by 39 · see citing works

The Regenerative Activity of Interleukin-6

Galun, E., & Rose-John, S. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-308-4_4 · Cited by 34 · see citing works

Murine Cardiotrophin-1 Stimulates the Acute-Phase Response in Rat Hepatocytes and H35 Hepatoma Cells

Richards, C. D., Langdon, C. M., Pennica, D., & Gauldie, J. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.69 · Cited by 32 · see citing works

Obesity Promotes Liver Carcinogenesis via Mcl-1 Stabilization Independent of IL-6Rα Signaling

Gruber, S. G., Straub, B. K., Ackermann, P., Wunderlich, C. M., Mauer, J., Seeger, J. M., Büning, H., Heukamp, L. C., Kashkar, H., Schirmacher, P., et al. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.023 · Cited by 32 · see citing works

Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model

Hatting, M., Spannbauer, M., Peng, J., Al Masaoudi, M., Sellge, G., Nevzorova, Y. A., Gassler, N., Liedtke, C., Cubero, F. J., & Trautwein, C. (2015) · Cell Death & Disease · doi:10.1038/cddis.2014.590 · Cited by 30 · see citing works

Elevated serum interleukin-6 levels in patients with acute hepatitis

Sun, Y.-Q., Tokushige, K., Isono, E., Yamauchi, K., & Obata, H. (1992) · Journal of Clinical Immunology · doi:10.1007/bf00918089 · Cited by 30 · see citing works

Interleukin 6 production by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection and primary biliary cirrhosis

Kakumu, S., Shinagawa, T., Ishikawa, T., et al. (1993) · Gastroenterologia Japonica · doi:10.1007/bf02774999 · Cited by 29 · see citing works

Assessment of Tocilizumab in the Treatment of Cancer Cachexia

Berti, A., Boccalatte, F. E., Sabbadini, M. G., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.4147 · Cited by 27 · see citing works

Oncogenic deletion mutants of gp130 signal from intracellular compartments

Schmidt‐Arras, D., Müller, M., Stevanovic, M., Horn, S., Schütt, A., Bergmann, J., Wilkens, R., Lickert, A., & Rose‐John, S. (2013) · Journal of Cell Science · doi:10.1242/jcs.130294 · Cited by 26 · see citing works

An acute phase protein ready to go therapeutic for sepsis

Vandevyver, S., Dejager, L., Vandenbroucke, R. E., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303524 · Cited by 26 · see citing works

gp130 activation is regulated by D2–D3 interdomain connectivity

Schütt, A., Zacharias, M., Schneider, N., et al. (2013) · Biochemical Journal · doi:10.1042/bj20121660 · Cited by 22 · see citing works

Hepatocyte senescence explains conjugated bilirubinaemia in chronic liver failure

Aravinthan, A. D., & Alexander, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.031 · Cited by 17 · see citing works

Interleukin-6 Trans-Signaling Regulates Glycogen Consumption After d -Galactosamine-Induced Liver Damage

Drucker, C., Rabe, B., Chalaris, A., Schulz, E., Scheller, J., & Rose‐John, S. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0095 · Cited by 15 · see citing works

Chimeric antigen receptor T-cell therapy—assessment and management of toxicities

Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W., Gutierrez, C., Locke, F. L., Komanduri, K. V., Lin, Y., Jain, N., Daver, N., et al. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.148 · Cited by 2,438 · see citing works

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

Zhang, C., Wu, Z., Li, J., Zhao, H., & Wang, G.-Q. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105954 · Cited by 1,758 · see citing works

Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations

MacParland, S. A., Liu, J. C., Ma, X.-Z., Innes, B. T., Bartczak, A. M., Gage, B. K., Manuel, J., Khuu, N., Echeverri, J., Linares, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06318-7 · Cited by 1,552 · see citing works

Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease

Chait, A., & den Hartigh, L. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00022 · Cited by 1,529 · see citing works

Interleukin-6 Family CytokinesPreprint

Rose‐John, S. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028415 · Cited by 801 · see citing works

Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities

Wen, Y., Lambrecht, J., Ju, C., & Tacke, F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00558-8 · Cited by 695 · see citing works

The endocrine function of adipose tissues in health and cardiometabolic disease

Scheja, L., & Heeren, J. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0230-6 · Cited by 663 · see citing works

Hepatocytes direct the formation of a pro-metastatic niche in the liver

Lee, J. W., Stone, M. L., Porrett, P. M., Thomas, S. K., Komar, C. A., Li, J. H., Delman, D., Graham, K., Gladney, W. L., Hua, X., et al. (2019) · Nature · doi:10.1038/s41586-019-1004-y · Cited by 402 · see citing works

Metabolic regulation of the immune system in health and diseases: mechanisms and interventions

Hu, T., Liu, C., Lei, M., Zeng, Q., Li, L., Tang, H., & Zhang, N. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01954-6 · Cited by 425 · see citing works

Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus

Burhans, M. S., Hagman, D. K., Kuzma, J. N., Schmidt, K. A., & Kratz, M. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170040 · Cited by 427 · see citing works

Regulation of Adipose Tissue Inflammation by Interleukin 6

Han, M. S., White, A., Perry, R. J., Camporez, J.-P., Hidalgo, J., Shulman, G. I., & Davis, R. J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1920004117 · Cited by 344 · see citing works

Interleukin 6 as an Energy Allocator in Muscle Tissue

Kistner, T. M., Pedersen, B. K., & Lieberman, D. E. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00538-4 · Cited by 295 · see citing works

Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression

Bohn, M. K., Hall, A., Sepiashvili, L., Jung, B., Steele, S., & Adeli, K. (2020) · Physiology · doi:10.1152/physiol.00019.2020 · Cited by 259 · see citing works

The Role of Complement in Liver Injury, Regeneration, and Transplantation

Thorgersen, E. B., Barratt‐Due, A., Haugaa, H., Harboe, M., Pischke, S. E., Nilsson, P. H., & Mollnes, T. E. (2019) · Hepatology · doi:10.1002/hep.30508 · Cited by 240 · see citing works

Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality

Costa, D., Simbrunner, B., Jachs, M., Hartl, L., Bauer, D. J. M., Paternostro, R., Schwabl, P., Scheiner, B., Stättermayer, A. F., Pinter, M., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.10.004 · Cited by 211 · see citing works

Myeloid‐Cell–Specific IL‐6 Signaling Promotes MicroRNA‐223‐Enriched Exosome Production to Attenuate NAFLD‐Associated Fibrosis

Hou, X., Yin, S., Ren, R., Liu, S., Yong, L., Liu, Y., Li, Y., Zheng, M., Kunos, G., Gao, B., et al. (2021) · Hepatology · doi:10.1002/hep.31658 · Cited by 223 · see citing works

Deep insight into cytokine storm: from pathogenesis to treatment

Nie, J., Zhou, L., Tian, W., Liu, X., Yang, L., Yang, X., Zhang, Y., Wei, S., Wang, D. W., & Wei, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02178-y · Cited by 224 · see citing works

Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease

de Gregorio, E., Colell, A., Morales, A., & Marı́, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113858 · Cited by 202 · see citing works

Role of C-Reactive Protein in Diabetic Inflammation

Stanimirović, J., Radovanović, J., Banjac, K., Obradovic, M. M., Essack, M., Zafirovic, S. S., Gluvic, Z. M., Gojobori, T., & Isenović, E. R. (2022) · Mediators of Inflammation · doi:10.1155/2022/3706508 · Cited by 214 · see citing works

Liver Regeneration: Analysis of the Main Relevant Signaling Molecules

Tao, Y.-C., Wang, M.-L., Chen, E., & Tang, H. (2017) · Mediators of Inflammation · doi:10.1155/2017/4256352 · Cited by 191 · see citing works

Senescence promotes in vivo reprogramming through p16<scp>^INK</scp>^4a and <scp>IL</scp>‐6

Mosteiro, L., Pantoja, C., de Martino, A., & Serrano, M. (2018) · Aging Cell · doi:10.1111/acel.12711 · Cited by 182 · see citing works

Liver Regeneration after Hepatectomy and Partial Liver Transplantation

Yagi, S., Hirata, M., Miyachi, Y., & Uemoto, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218414 · Cited by 192 · see citing works

Inflammatory cytokines and change of Th1/Th2 balance as prognostic indicators for hepatocellular carcinoma in patients treated with transarterial chemoembolization

Lee, H. L., Jang, J. W., Lee, S. W., Yoo, S. H., Kwon, J. H., Nam, S. W., Bae, S. H., Choi, J. Y., Han, N. I., & Yoon, S. K. (2019) · Scientific Reports · doi:10.1038/s41598-019-40078-8 · Cited by 185 · see citing works

Effects of aging on liver microcirculatory function and sinusoidal phenotype

Maeso‐Díaz, R., Ortega‐Ribera, M., Fernández‐Iglesias, A., Hide, D., Muñoz, L., Hessheimer, A. J., Vila, S., Francés, R., Fondevila, C., Albillos, A., et al. (2018) · Aging Cell · doi:10.1111/acel.12829 · Cited by 175 · see citing works

A Mendelian randomization study of IL6 signaling in cardiovascular diseases, immune-related disorders and longevity

Rosa, M., Chignon, A., Li, Z., Boulanger, M., Arsenault, B. J., Bossé, Y., Thériault, S., & Mathieu, P. (2019) · npj Genomic Medicine · doi:10.1038/s41525-019-0097-4 · Cited by 167 · see citing works

T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy

Zhai, Y., Wang, J., Lang, T., Kong, Y., Rong, R., Cai, Y., Ran, W., Xiong, F., Zheng, C., Wang, Y., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00972-7 · Cited by 170 · see citing works

The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity

Kasselman, L. J., Vernice, N. A., DeLeon, J. R., & Reiss, A. B. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.02.036 · Cited by 159 · see citing works

Interleukin-6: A Novel Target for Cardio-Cerebrovascular Diseases

Su, J.-H., Luo, M.-Y., Liang, N., Gong, S.-X., Chen, W., Huang, W., Tian, Y., & Wang, A. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.745061 · Cited by 160 · see citing works

Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition

Li, Y., Zheng, Q., Zou, L., et al. (2019) · Pediatric Rheumatology · doi:10.1186/s12969-018-0303-4 · Cited by 155 · see citing works

Mesenchymal stromal cell-derived exosome-rich fractionated secretome confers a hepatoprotective effect in liver injury

Damania, A., Jaiman, D., Teotia, A. K., & Kumar, A. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0752-6 · Cited by 150 · see citing works

Acute liver failure is regulated by MYC- and microbiome-dependent programs

Kolodziejczyk, A. A., Federici, S., Zmora, N., Mohapatra, G., Dori-Bachash, M., Hornstein, S., Leshem, A., Reuveni, D., Zigmond, E., Tobar, A., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1102-2 · Cited by 148 · see citing works

Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease

Kostrzewski, T. M., Cornforth, T. V., Snow, S., Ouro-Gnao, L., Rowe, C., Large, E. M., & Hughes, D. J. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i2.204 · Cited by 149 · see citing works

Leukocytes, Systemic Inflammation and Immunopathology in Acute-on-Chronic Liver Failure

Casulleras, M., Zhang, I. W., López‐Vicario, C., & Clària, J. (2020) · Cells · doi:10.3390/cells9122632 · Cited by 137 · see citing works

IL‐6 trans‐signaling is essential for the development of hepatocellular carcinoma in mice

Bergmann, J., Müller, M., Baumann, N., Reichert, M., Heneweer, C., Bolik, J., Lücke, K., Gruber, S., Carambia, A., Boretius, S., et al. (2017) · Hepatology · doi:10.1002/hep.28874 · Cited by 152 · see citing works

Immunopathobiology and therapeutic targets related to cytokines in liver diseases

He, Y., Hwang, S., Ahmed, Y. A., Feng, D., Li, N., Ribeiro, M. D. C., Lafdil, F., Kisseleva, T., Szabó, G., & Gao, B. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00580-w · Cited by 136 · see citing works

Distinct Effects of IL-6 Classic and Trans -Signaling in Bone Fracture Healing

Prystaz, K., Kaiser, K., Kovtun, A., Haffner-Luntzer, M., Fischer, V., Rapp, A. E., Liedert, A., Strauss, G., Waetzig, G. H., Rose-John, S., et al. (2018) · The American Journal of Pathology · doi:10.1016/j.ajpath.2017.10.011 · Cited by 142 · see citing works

StackIL6: a stacking ensemble model for improving the prediction of IL-6 inducing peptides

Charoenkwan, P., Chiangjong, W., Nantasenamat, C., Hasan, M. M., Manavalan, B., & Shoombuatong, W. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab172 · Cited by 134 · see citing works

Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease

Michailidou, Z., Gomez-Salazar, M. A., & Alexaki, V. I. (2021) · Journal of Innate Immunity · doi:10.1159/000515117 · Cited by 137 · see citing works

Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target

Qian, W., Zhao, M., Wang, R., & Li, H. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01161-8 · Cited by 136 · see citing works

Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH

Dong, J., Viswanathan, S., Adami, E., Singh, B. K., Chothani, S. P., Ng, B., Lim, W., Zhou, J., Tripathi, M., Ko, N. S. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20303-z · Cited by 125 · see citing works

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis

Lee, C., Kim, J., & Jung, Y. (2019) · Cells · doi:10.3390/cells8101259 · Cited by 123 · see citing works

The liver in sepsis: molecular mechanism of liver failure and their potential for clinical translation

Beyer, D., Hoff, J., Sommerfeld, O., Zipprich, A., Gaßler, N., & Press, A. T. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00510-8 · Cited by 122 · see citing works

Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!

Coperchini, F., Chiovato, L., & Rotondi, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.668507 · Cited by 116 · see citing works

Pathogenesis of Kupffer Cells in Cholestatic Liver Injury

Sato, K., Hall, C. M., Glaser, S. S., Francis, H., Meng, F., & Alpini, G. D. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.06.003 · Cited by 120 · see citing works

The immune niche of the liver

Cheng, M. L., Nakib, D., Perciani, C. T., & MacParland, S. A. (2021) · Clinical Science · doi:10.1042/cs20190654 · Cited by 122 · see citing works

Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma

Nevola, R., Tortorella, G., Rosato, V., Rinaldi, L., Imbriani, S., Perillo, P., Mastrocinque, D., Montagna, M. L., Russo, A., Lorenzo, G. D., et al. (2023) · Biology · doi:10.3390/biology12070984 · Cited by 116 · see citing works

Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis

Savage, T. M., Fortson, K. T., de los Santos-Alexis, K., Oliveras-Alsina, A., Rouanne, M., Rae, S. S., Gamarra, J. R., Shayya, H., Kornberg, A., Cavero, R., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.01.009 · Cited by 115 · see citing works

Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy

McConnell, M. J., Kawaguchi, N., Kondo, R., Sonzogni, A., Licini, L., Valle, C., Bonaffini, P. A., Sironi, S., Alessio, M. G., Previtali, G., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.050 · Cited by 111 · see citing works

Quercetin reduces atherosclerotic lesions by altering the gut microbiota and reducing atherogenic lipid metabolites

Nie, J., Zhang, L., Zhao, G., et al. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14441 · Cited by 110 · see citing works

Unraveling the Role of Leptin in Liver Function and Its Relationship with Liver Diseases

Martinez‐Uña, M., López‐Mancheño, Y., Diéguez, C., Fernandez-Rojo, M. A., & Novelle, M. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249368 · Cited by 115 · see citing works

Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies

Yasmeen, F., Pirzada, R. H., Ahmad, B., Choi, B., & Choi, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147666 · Cited by 119 · see citing works

ADAM17 Activity and IL-6 Trans-Signaling in Inflammation and Cancer

Schumacher, N., & Rose‐John, S. (2019) · Cancers · doi:10.3390/cancers11111736 · Cited by 103 · see citing works

ER stress and inflammation crosstalk in obesity

Ajoolabady, A., Lebeaupin, C., Wu, N. N., Kaufman, R. J., & Ren, J. T. (2022) · Medicinal Research Reviews · doi:10.1002/med.21921 · Cited by 106 · see citing works

Both MAPK and STAT3 signal transduction pathways are necessary for IL-6-dependent hepatic stellate cells activation

Kagan, P., Sultan, M., Tachlytski, I., Safran, M., & Ben‐Ari, Z. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176173 · Cited by 100 · see citing works

From Infection to Death: An Overview of the Pathogenesis of Visceral Leishmaniasis

Costa, C. H. N., Chang, K. P., Costa, D. L., & Cunha, F. V. M. (2023) · Pathogens · doi:10.3390/pathogens12070969 · Cited by 109 · see citing works

CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway

Zhao, Z., Song, J., Tang, B., Fang, S., Zhang, D., Zheng, L., Wu, F., Gao, Y., Chen, C., Hu, X., et al. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01769-7 · Cited by 97 · see citing works

Emerging role of aging in the progression of NAFLD to HCC

He, Y., Su, Y., Duan, C., Wang, S., He, W. G., Zhang, Y., An, X., & He, M. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101833 · Cited by 98 · see citing works

Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading

Goldstein, I., Paakinaho, V., Baek, S., Sung, M.-H., & Hager, G. L. (2017) · Nature Communications · doi:10.1038/s41467-017-02055-5 · Cited by 97 · see citing works

Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology

Bolshette, N. B., Ibrahim, H., Reinke, H., & Asher, G. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00792-1 · Cited by 99 · see citing works

Cancer-associated fibroblasts promote the stemness of CD24+ liver cells via paracrine signaling

Li, Y., Wang, R., Xiong, S., Wang, X., Zhao, Z., Bai, S., Wang, Y., Zhao, Y., & Cheng, B. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1731-9 · Cited by 96 · see citing works

The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa

Gallo, D. J., de la Varga‐Martínez, R., Ossorio‐García, L., et al. (2017) · Mediators of Inflammation · doi:10.1155/2017/2450401 · Cited by 96 · see citing works

Differential regulation of hepcidin in cancer and non-cancer tissues and its clinical implications

Vela, D., & Vela‐Gaxha, Z. (2018) · Experimental & Molecular Medicine · doi:10.1038/emm.2017.273 · Cited by 94 · see citing works

Organ System Crosstalk in Cardiometabolic Disease in the Age of Multimorbidity

Oishi, Y., & Manabe, I. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00064 · Cited by 96 · see citing works

The anti-inflammatory effects of Akkermansia muciniphila and its derivates in HFD/CCL4-induced murine model of liver injury

Raftar, S. K. A., Ashrafian, F., Abdollahiyan, S., Yadegar, A., Moradi, H. R., Masoumi, M., Vaziri, F., Moshiri, A., Siadat, S. D., & Zali, M. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-06414-1 · Cited by 97 · see citing works

Markers of liver regeneration—the role of growth factors and cytokines: a systematic review

Hoffmann, K., Nagel, A. J., Tanabe, K., Fuchs, J., Dehlke, K., Ghamarnejad, O., Lemekhova, A., & Mehrabi, A. (2020) · BMC Surgery · doi:10.1186/s12893-019-0664-8 · Cited by 94 · see citing works

Cytokines as therapeutic targets for cardio- and cerebrovascular diseases

Liberale, L., Ministrini, S., Carbone, F., Camici, G. G., & Montecucco, F. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00863-x · Cited by 93 · see citing works

Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study)

Sigurdardottir, F. D., Lyngbakken, M. N., Holmen, O. L., Dalen, H., Hveem, K., Røsjø, H. R., & Omland, T. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.01.004 · Cited by 91 · see citing works

Senescent hepatic stellate cells promote liver regeneration through IL-6 and ligands of CXCR2

Cheng, N., Kim, K.-H., & Lau, L. F. (2022) · JCI Insight · doi:10.1172/jci.insight.158207 · Cited by 87 · see citing works

Modeling alcohol-associated liver disease in a human Liver-Chip

Nawroth, J. C., Petropolis, D. B., Manatakis, D. V., Maulana, T. I., Burchett, G., Schlünder, K., Witt, A., Shukla, A., Kodella, K., Ronxhi, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109393 · Cited by 88 · see citing works

Systemic inflammation as fuel for acute liver injury in COVID-19

Effenberger, M., Grander, C., Grabherr, F., Griesmacher, A., Ploner, T., Hartig, F., Bellmann-Weiler, R., Joannidis, M., Zoller, H., Weiss, G., et al. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.08.004 · Cited by 87 · see citing works

The double-edged effects of IL-6 in liver regeneration, aging, inflammation, and diseases

Wang, M.-J., Zhang, H.-L., Chen, F., Guo, X.-J., Liu, Q.-G., & Hou, J. (2024) · Experimental Hematology &amp; Oncology · doi:10.1186/s40164-024-00527-1 · Cited by 84 · see citing works

Liver Inflammation and Hepatobiliary Cancers.

Leone, V., Ali, A., Weber, A., Tschaharganeh, D., & Heikenwalder, M. (2021) · Trends in Cancer · doi:10.1016/j.trecan.2021.01.012 · Cited by 79 · see citing works

Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy

Myojin, Y., Kodama, T., Sakamori, R., Maesaka, K., Matsumae, T., Sawai, Y., Imai, Y., Ohkawa, K., Miyazaki, M., Tanaka, S., et al. (2022) · Cancers · doi:10.3390/cancers14040883 · Cited by 84 · see citing works

Emerging role of IL-6 and NLRP3 inflammasome as potential therapeutic targets to combat COVID-19: Role of lncRNAs in cytokine storm modulation

Paniri, A., & Akhavan‐Niaki, H. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118114 · Cited by 81 · see citing works

The Role of Autophagy for the Regeneration of the Aging Liver

Xu, F., Hua, C., Tautenhahn, H., Dirsch, O., & Dahmen, U. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103606 · Cited by 80 · see citing works

Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis

Simon, T. G., Trejo, M. E. P., McClelland, R. L., Bradley, R. D., Blaha, M. J., Zeb, I., Corey, K. E., Budoff, M. J., & Chung, R. T. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.01.046 · Cited by 80 · see citing works

Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation

Barchetta, I., Cimini, F. A., Ciccarelli, G., Baroni, M. G., & Cavallo, M. G. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01052-3 · Cited by 77 · see citing works

Hypoxia‐Inducible Factor‐2α Reprograms Liver Macrophages to Protect Against Acute Liver Injury Through the Production of Interleukin‐6

Gao, R. Y., Wang, M., Liu, Q., Feng, D., Wen, Y., Xia, Y., Colgan, S. P., Eltzschig, H. K., & Ju, C. (2019) · Hepatology · doi:10.1002/hep.30954 · Cited by 79 · see citing works

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update

Aletaha, D., Kerschbaumer, A., Kastrati, K., Dejaco, C., Dougados, M., McInnes, I. B., Sattar, N. A., Stamm, T., Takeuchi, T., Trauner, M. A., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-222784 · Cited by 80 · see citing works

Kidney–liver pathophysiological crosstalk: its characteristics and importance

Capalbo, O. M., Giuliani, S., Ferrero-Fernández, A., et al. (2019) · International Urology and Nephrology · doi:10.1007/s11255-019-02288-x · Cited by 78 · see citing works

Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Improve Liver Regeneration After Ischemia Reperfusion Injury in Mice

Anger, F., Camara, M., Ellinger, E., et al. (2019) · Stem Cells and Development · doi:10.1089/scd.2019.0085 · Cited by 77 · see citing works

Virulent Pseudorabies Virus Infection Induces a Specific and Lethal Systemic Inflammatory Response in Mice

Laval, K., Vernejoul, J. B., Cleemput, J. V., Koyuncu, O. Ö., & Enquist, L. W. (2018) · Journal of Virology · doi:10.1128/jvi.01614-18 · Cited by 80 · see citing works

Effect of perfluorooctane sulphonate-induced Kupffer cell activation on hepatocyte proliferation through the NF-κB/TNF-α/IL-6-dependent pathway

Han, R., Zhang, F., Wan, C., et al. (2018) · Chemosphere · doi:10.1016/j.chemosphere.2018.02.137 · Cited by 76 · see citing works

Impact of Lipotoxicity on Tissue “Cross Talk” and Metabolic Regulation

Montgomery, M. K., Nardo, W. D., & Watt, M. J. (2019) · Physiology · doi:10.1152/physiol.00037.2018 · Cited by 78 · see citing works

Biomarkers of Macrophage Activation and Immune Danger Signals Predict Clinical Outcomes in Alcoholic Hepatitis

Saha, B., Tornai, D., Kodys, K., Adejumo, A., Lowe, P., McClain, C. J., Mitchell, M. C., McCullough, A. J., Dasarathy, S., Kroll‐Desrosiers, A., et al. (2019) · Hepatology · doi:10.1002/hep.30617 · Cited by 75 · see citing works

Dietary Lactobacillus reuteri prevent from inflammation mediated apoptosis of liver via improving intestinal microbiota and bile acid metabolism

Lin, Z., Wu, J., Wang, J., Levesque, C. L., & Ma, X. (2022) · Food Chemistry · doi:10.1016/j.foodchem.2022.134643 · Cited by 75 · see citing works

Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-19

Brábek, J., Jakubek, M., Vellieux, F. M. D., Novotný, J., Kolář, M., Lacina, L., Szabó, P., Strnadová, K., Rösel, D., Dvořánková, B., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217937 · Cited by 73 · see citing works

Interleukin-6: A promising cytokine to support liver regeneration and adaptive immunity in liver pathologies

Naseem, S., Hussain, T., & Manzoor, S. (2018) · Cytokine &amp; Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.01.002 · Cited by 72 · see citing works

Therapeutic Effect of Dunaliella salina Microalgae on Thioacetamide- (TAA-) Induced Hepatic Liver Fibrosis in Rats: Role of TGF- β and MMP9

El-Baz, F. K., Salama, A., & Elgohary, R. (2019) · BioMed Research International · doi:10.1155/2019/7028314 · Cited by 72 · see citing works

The determinant role of IL-6 in the establishment of inflammation leading to spontaneous preterm birth

Prairie, É., Côté, F., Tsakpinoglou, M., Mina, M., Quiniou, C., Leimert, K. B., Olson, D. M., & Chemtob, S. (2021) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.12.004 · Cited by 74 · see citing works

Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma

Kaiser, K., Prystaz, K., Vikman, A., Haffner‐Luntzer, M., Bergdolt, S., Strauß, G., Waetzig, G. H., Rose‐John, S., & Ignatius, A. A. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1483-7 · Cited by 72 · see citing works

Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation

Lee, S. R., Kwon, S. W., Lee, Y. H., Kaya, P., Kim, J. M., Ahn, C., Jung, E., Lee, G., An, B., Jeung, E., et al. (2019) · BMC Cancer · doi:10.1186/s12885-018-5222-8 · Cited by 71 · see citing works

Effects of Chronic Intermittent Hypoxia and Chronic Sleep Fragmentation on Gut Microbiome, Serum Metabolome, Liver and Adipose Tissue Morphology

Wang, F., Zou, J., Xu, H., Huang, W., Zhang, X., Wei, Z., Li, X., Liu, Y., Zou, J., Liu, F., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.820939 · Cited by 71 · see citing works

NAFLD and HBV interplay - related mechanisms underlying liver disease progression

Tourkochristou, E., Assimakopoulos, S. F., Thomopoulos, K., Marangos, M., & Triantos, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.965548 · Cited by 70 · see citing works

A blood-based prognostic liver secretome signature and long-term hepatocellular carcinoma risk in advanced liver fibrosis

Fujiwara, N., Kobayashi, M., Fobar, A. J., Hoshida, A., Marquez, C. A., Koneru, B., Panda, G., Taguri, M., Qian, T., Raman, I., et al. (2021) · Med · doi:10.1016/j.medj.2021.03.017 · Cited by 70 · see citing works

IL-6 Directed Therapy in Transplantation

Miller, C. L., & Madsen, J. C. (2021) · Current Transplantation Reports · doi:10.1007/s40472-021-00331-4 · Cited by 71 · see citing works

Dynamic human liver proteome atlas reveals functional insights into disease pathways

Niu, L., Geyer, P. E., Gupta, R., Santos, A., Meier, F., Doll, S., Albrechtsen, N. J. W., Klein, S., Ortiz, C., Uschner, F. E., et al. (2022) · Molecular Systems Biology · doi:10.15252/msb.202210947 · Cited by 65 · see citing works

Aging of Liver in Its Different Diseases

Radonjić, T., Dukić, M., Jovanović, I., Zdravkovic, M. D., Mandić, O., Popadić, V., Popović, M., Nikolić, N., Klašnja, S., Divac, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113085 · Cited by 76 · see citing works

G protein-coupled estrogen receptor deficiency accelerates liver tumorigenesis by enhancing inflammation and fibrosis

Wei, T., Chen, W., Wen, L., Zhang, J., Zhang, Q., Yang, J., Liu, H., Chen, B. W., Zhou, Y., Feng, X., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.08.012 · Cited by 70 · see citing works

Functional role of skeletal muscle-derived interleukin-6 and its effects on lipid metabolism

Lin, W., Song, H., Shen, J., Wang, J., Yang, Y., Yang, Y., Cao, J., Xue, L., Zhao, F., Xiao, T., et al. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1110926 · Cited by 67 · see citing works

Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration

Peters, M., Blinn, G., Jostock, T., Schirmacher, P., Büschenfelde, K. M. Z., Galle, P. R., & Rose–John, S. (2000) · Gastroenterology · doi:10.1053/gast.2000.20236 · Cited by 129 · see citing works

Hepatocyte-specific Ablation in Zebrafish to Study Biliary-driven Liver Regeneration

Choi, T., Khaliq, M., Ko, S., So, J., & Shin, D. (2015) · Journal of Visualized Experiments · doi:10.3791/52785 · Cited by 17 · see citing works

[Cellular mechanisms of cirrhotic rat liver regeneration. II. Proliferation, polyploidization and hypertrophy after partial hepatectomy].

Sakuta, G. A., & Bn, K. (2005) · PubMed · Cited by 5 · see citing works

Hepatic NF-kB-inducing Kinase (NIK) Suppresses Liver Regeneration in Chronic Liver DiseasePreprint

Xiong, Y., Torsoni, A. S., Wu, F., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/238717 · Cited by 3 · see citing works

Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings

Seki, E., Kondo, Y., Iimuro, Y., Naka, T., Son, G., Kishimoto, T., Fujimoto, J., Tsutsui, H., & Nakanishi, K. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.020 · Cited by 50 · see citing works